Trials / Terminated
TerminatedNCT01259986
Treatment of Vitiligo With Low-energy Visible Light Laser
Treatment of Recalcitrant Forms of Vitiligo With a Low-energy 635 nm Visible Light Laser
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 3 (actual)
- Sponsor
- Henry Ford Health System · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is the evaluate the efficacy of using a low-energy 635 nm visible light laser in the treatment of various recalcitrant forms of vitiligo.
Detailed description
Vitiligo is a pigmentary disorder characterized by depigmented and hypopigmented macules and patches. There are forms of vitiligo which are more resistant to treatment, including segmental vitiligo and acral vitiligo. Previous studies have shown that a low energy helium-neon (633 nm) laser can cause increased proliferation of melanocytes and repigmentation in segmental-type vitiligo. The goal of this study is to verify these results and show efficacy in other recalcitrant forms of vitiligo including acral vitiligo and post melanocyte-keratinocyte transplantation vitiligo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Laser treatment | Laser treatment of using 635 nm laser with a dose of 3.0 J/cm\^2 to small area (2cm x 2cm) of vitiligo once to twice a week for a total of 12 weeks. |
Timeline
- Start date
- 2010-10-01
- Primary completion
- 2011-06-01
- Completion
- 2012-09-01
- First posted
- 2010-12-15
- Last updated
- 2012-09-27
Source: ClinicalTrials.gov record NCT01259986. Inclusion in this directory is not an endorsement.